Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1900 of 2228 entries
View as:

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT01111318 Org: User:
Start: 07/31/10 End: - Due: -

Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT01965431 Org: User:
Start: 10/31/13 End: 01/31/14 Due: 01/31/15

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02256813 Org: User:
Start: 09/30/05 End: - Due: -

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT01211197 Org: User:
Start: 10/31/10 End: - Due: -

Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT02242331 Org: User:
Start: 06/30/01 End: - Due: -

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm

Phase: N/A Priority: Normal
NCT ID: NCT02182713 Org: User:
Start: 05/31/98 End: - Due: -

Evaluation of the Effect of Multiple Dosing With BI 201335 on CYP2B6 Metabolism and Effect of Multiple Dosing With Efavirenz on the Steady-state Pharmacokinetics of BI 201335 and on CYP3A4/5 Metabolism in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01371006 Org: User:
Start: 06/30/11 End: - Due: -

A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02182063 Org: User:
Start: 11/30/05 End: - Due: -

A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

Phase: N/A Priority: Normal
NCT ID: NCT05155306 Org: User:
Start: 01/14/22 End: 05/16/22 Due: 05/16/23

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02273518 Org: User:
Start: 04/30/01 End: - Due: -

An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02182206 Org: User:
Start: 06/30/03 End: - Due: -

(Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis

Phase: N/A Priority: Normal
NCT ID: NCT00932737 Org: User:
Start: 06/09/09 End: 02/08/10 Due: 02/08/11

A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT04399837 Org: User:
Start: 06/04/20 End: 11/23/22 Due: 11/23/23

Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02203500 Org: User:
Start: 10/31/98 End: - Due: -

Study to Assess the Effect of Food on the Pharmacokinetics of Meloxicam After Single Administration and to Investigate Dose-proportionality Over a Dosage Range

Phase: N/A Priority: Normal
NCT ID: NCT02181322 Org: User:
Start: 06/30/01 End: - Due: -

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02238171 Org: User:
Start: 04/30/00 End: - Due: -

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1323495 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04011241 Org: User:
Start: 07/24/19 End: 09/06/19 Due: 09/06/20

Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial

Phase: N/A Priority: Normal
NCT ID: NCT00157261 Org: User:
Start: 01/31/04 End: 06/30/06 Due: 06/30/07

Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06370871 Org: User:
Start: 06/27/24 End: 10/13/28 Due: 10/13/29

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02171702 Org: User:
Start: 11/30/04 End: - Due: -

A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT03837964 Org: User:
Start: 02/27/19 End: 04/24/19 Due: 04/24/20

Bioequivalence of a Fixed Dose Combination Tablet Containing 200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl Compared to RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) as a Fixed Dose Combination Tablet Administered in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT01170637 Org: User:
Start: 07/31/10 End: - Due: -

Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00267943 Org: User:
Start: 01/31/06 End: 01/31/07 Due: 01/31/08

Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03175211 Org: User:
Start: 06/30/17 End: 02/19/18 Due: 02/19/19

Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00720499 Org: User:
Start: 07/31/08 End: - Due: -